Clinical Study
Morbidity and Mortality Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy at a Single Institution in Japan
Table 2
Morbidity and mortality after cytoreductive surgery.
| | Grades I/II | Grades III/IV | Grade V | All | Reoperation |
| SSIs; intraabdominal abscess | 52 | 12 | | 64 | 4 | Gastric or intestinal perforation | 2 | 13 | | 15 | 11 | Postoperative ileus | 9 | 5 | | 14 | 2 | Anastomotic leakage | 3 | 6 | 3 | 12 | 4 | Urinary disturbance | 9 | 1 | | 10 | | Intestinal fistula | 5 | 3 | 1 | 9 | 2 | Postoperative bleeding | | 6 | 2 | 8 | 8 | Sepsis | | | 3 | 3 | | DIC | | 1 | 1 | 2 | | Respiratory distress | | 1 | | 1 | | Diaphragmatic hernia | ć | 1 | ć | 1 | 1 |
| Total | 80 | 49 | 10 | 139 | 32 |
|
|
SSIs: surgical site infections.
|